Modulation of mucin synthesis by γ-interferon in human colon adenocarcinoma cells

Digestion

Volumn 67, Issue 1-2, 2003, Pages 50-55

  Niv, Yaron ^a   Koren, Rivka ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Interferon; CACO2; Colorectal cancer; HT 29; LIM 6; LS174T; Mucin; Mucin antigens

Indexed keywords

GAMMA INTERFERON; GLUCOSAMINE; MUCIN; SEPHAROSE;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN; CELL STRAIN CACO 2; COLON ADENOCARCINOMA; CONTROLLED STUDY; GEL FILTRATION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STANDARD;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSAMINE; HUMANS; INTERFERON-GAMMA, RECOMBINANT; MUCINS; TUMOR CELLS, CULTURED;

EID: 0038215625     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069706     Document Type: Article

References (41)

1. Fillipe MI: Mucins in the human gastrointestinal epithelium: A review. Invest Cell Pathol 1979;2:295-316.
2. Neutra MR, Forstrer JF: Gastrointestinal mucus: Synthesis, secretion and function; in Johnson DF (ed): Physiology of the Gastrointestinal Tract, ed 2. New York, Raven, 1987, pp 975-1009.
3. Gum JR, Byrd JC, Hicks JW, Toribara NW, Lamport DTA, Siddiki B, Kim YS: Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem 1989;264:6480-6487.
4. Gum JR, Hicks JW, Swallow DM, Lagace RE, Byrd JC, Lamport DTA, Siddiki B, Kim YS: Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. Biochem Biophys Res Commun 1990;171:407-415.
5. Kim YS: Mucin glycoprotein alterations in the gastrointestinal and metastasis. Eur J Gastroenterol Hepatol 1993;5:219-225.
6. Gendler SJ, Spicer AP: Epithelial mucin genes. Annu Rev Physiol 1995;57:607-634.
7. Kim YS, Gum JR: Diversity of mucin genes, structure, function and expression. Gastroenterology 1995;109:999-1013.
8. Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT: Colloid carcinoma of the colon and rectum. Cancer 1987;60:3103-3112.
9. Sasaki O, Atkin WS, Jass JR: Mucinous carcinoma of the rectum. Histopathology 1987;11:259-272.
10. Niv Y: Colorectal mucinous adenocarcinoma. Harefuah 1991;120:151-153.
11. Niv Y: Signet ring cell carcinoma of the colon and rectum. Harefuah 1991;120:216-218.
12. Connelly JH, Robey-Cafferty SS, Cleary KR: Mucinous carcinomas of the colon and rectum. An analysis of 62 stage B and C lesions. Arch Pathol Lab Med 1991;115:1022-1025.
13. Niv Y, Boland CR, Kim YS: Increased tumorigenicity after differentiation of colon cancer cell line: Absence of association with mucin synthesis. Gastroenterology 1994;106:389-398.
14. Bresalier RS, Niv Y, Bryd JC, Duh K, Toribara NW, Kim YS: Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 1991;87:1037-1045.
15. Niv Y: Mucin and colorectal cancer metastasis. Am J Gastroenterol 1994;89:665-669.
16. Niv Y, Byrd JC, Ho SB, Dahiya R, Kim YS: Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitro. Int J Cancer 1992;50:147-152.
17. Niv Y, Kim YS: The effect of serum in the growth medium on mucin synthesis by colon cancer cell line. Isr J Med Sci 1995;31:600-603.
18. Powrie F, Mason D: Phenotypic and functional heterogeneity of CD4+ T cells. Immunol Today 1988;9:274-277.
19. Lowes JR, Priddle JD, Jewell DP: The effect of differentiation on HLA-DR expression and induction by γ-interferon on the epithelial cell line HT-29. Gastroenterology 1989;96(suppl):A308.
20. Guadagni F, Witt PL, Robins PF, Schlom J, Greiner JW: Regulation of CEA expression in different human colorectal tumor cells by interferon-γ. Cancer Res 1990;50:6248-6255.
21. Vitolo D, Zerbe T, Kanbour A, Dahl C, Herberman RB, Whiteside TL: Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer 1992;51:573-580.
22. Malik ST, Knowles RG, East N, Lando D, Stamp G, Balkwill FR: Antitumor activity of γ-interferon in ascitic and solid tumor models of human ovarian cancer. Cancer Res 1991;51:6643-6649.
23. 131I-CC49) when given in combination with γ-interferon. Cancer Res 1993;53:600-608.
24. 2-6GalNAc α-O-Ser/Thr (sialyl-Tn). Int J Cancer 1993;55:148-152.
25. Clark S, McGuckin MA, Hurst T, Ward BG: Effect of interferon-γ and TNF-α on MUC1 mucin expression in ovarian carcinoma cell lines. Dis Markers 1994;12:43-50.
26. Niv Y, Schwartz B, Amsalem Y, Lamprecht SA: Human HT-29 colon carcinoma cells: Mucin production and tumorigenicity in relation to growth phases. Anticancer Res 1995;15:2023-2028.
27. Shekels LL, Lyftogt C, Kieliszewski M, Fiue JD, Kozak CA, Ho SB: Mouse gastric mucin: Cloning and chromosomal localization. Biochem J 1995;311:775-785.
28. Turner BS, Bhaskar KR, Hadzopoulou-Cladaras M, Specian RD, LaMont JT: Isolation and characterization of cDNA clones encoding pig gastric mucin. Biochem J 1995;308:89-96.
29. Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk W: IFN-γ and TNF-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 1999;116:238-245.
30. Fish SM, Proujansky R, Reenstra WW: Synergistic effects of interferon-γ and tumor necrosis factor-α on T84 cell function. Gut 1999;45:191-198.
31. Xu X, Fu XY, Plate J, Chong AS: INF-γ induces cell growth inhibition by Fas-mediated apoptosis: Requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res 1998;58:2832-2837.
32. Di Paolo MC, Merrett MN, Crotty B, Jewell DP: 5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by γ-interferon. Gut 1996;38:115-119.
33. Junming L, Jia-Cheng H: Production of soluble HLA-class-I molecules by INF-λ-induced colon adenocarcinoma cells. Int J Cancer 1995;60:576-581.
34. Lotem J, Sachs L: Interferon-γ inhibits apoptosis induced by wild-type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells. Leukemia 1995;9:685-692.
35. Carol M, Lambrechts A, van Gossum A, Libin M, Goldman M, Mascart-Lemon F: Spontaneous secretion of interferon-γ and interleukin-4 by human intraepithelial and lamina propria gut lymphocytes. Gut 1998;42:643-649.
36. Simonitsch I, Krupitza G: Autocrine self-elimination of cultured ovarian cancer cells by tumor necrosis factor-α. Br J Cancer 1998;78:862-870.
37. Lutz W, Fulda S, Jeremias I, Debatin KM, Schwab M: MycN and IFN-γ cooperate in apoptosis of human neuroblastoma cells. Oncogene 1998;17:339-346.
38. Burke F, Smith PD, Crompton MR, Upton C, Balkwill FR: Cytotoxic response of ovarian cancer cell lines to INF-λ is associated with sustained induction of IRF-1 and p21 mRNA. Br J Cancer 1999;80:1236-1244.
39. Barshishat M, Polak-Charcon S, Schwartz B: Butyrate regulates E-cadherin transcription, isoform expression and intercellular position in colon cancer cells. Br J Cancer 2000;82:195-203.
40. Kucerova D, Stokrova J, Korb J, Sloncova E, Tuhackova Z, Sovova VV: Response of HT29 cells to butyrate depends on time of exposure and glucose deprivation. Int J Mol Med 2002;10:779-784.
41. Barshishat M, Ariel A, Chahalon L, Chowers Y, Lider O, Schwartz B: TNF-α and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells. Clin Exp Metastasis 2002;19:327-337.